awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36306554-F8427E1A-EEF8-4D19-8C8E-2DC2806EA9A0
Q36306554-F8427E1A-EEF8-4D19-8C8E-2DC2806EA9A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36306554-F8427E1A-EEF8-4D19-8C8E-2DC2806EA9A0
A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
P2860
Q36306554-F8427E1A-EEF8-4D19-8C8E-2DC2806EA9A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36306554-F8427E1A-EEF8-4D19-8C8E-2DC2806EA9A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
898271b4c40839c637ca7b9adce908f90e3b713a
P2860
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan.